Prospective comparative effectiveness trial of carbon ion therapy, surgery, and proton therapy for the management of pelvic sarcomas (soft tissue/bone) involving the bone
Not Applicable
- Conditions
- pelvic bone or soft tissue sarcomas involving pelvic bone
- Registration Number
- JPRN-UMIN000053705
- Lead Sponsor
- Mayo Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
Patients receiving palliative treatment Recurrent disease Males and females <15 years of age Previous radiation therapy to the site of the sarcoma or area surrounding it such that it would be partially or completely encompassed by the radiation volume needed to treat the current sarcoma. In other words, treatment on this study would require re-irradiation of tissues. Patients with distant sarcoma metastases Benign pelvic bone histologies Any of the following: Pregnant women Nursing women Men or women of childbearing potential who are unwilling to employ adequate contraception
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To demonstrate whether carbon ion therapy provides improved patient reported health related quality of life (PRO-HRQOL) outcomes and less significant toxicities.
- Secondary Outcome Measures
Name Time Method To demonstrate whether carbon ion therapy provides improved local control versus proton therapy.